You just read:

Protagonist Therapeutics Receives SBIR Funding for the Development of Injectable Hepcidin Mimetics for Treatment of Iron Overload Disorders

News provided by

Protagonist Therapeutics, Inc.

Jul 28, 2016, 08:00 ET